KALV Stock-Based Compensation
Kalvista Pharmaceuticals Inc · Stock-Based Compensation
KALV Stock-Based Compensation
Latest reported$5.38Mperiod ending
KALV Stock-Based Comp ($47.00K → $5.38M)
Annual stock-based compensation
High-resolution chart · PNG
KALV stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 0 | |
| 12,291,000 | |
| 21,915,000 | |
| 9,922,000 | |
| 0 | |
| 7,118,000 | |
| 4,448,000 | |
| 2,966,000 | |
| 1,060,000 | |
| 394,000 | |
| 118,000 | |
| 36,000 | |
| 238,000 | |
| 47,000 |